Business Context and Reporting Period
This Form 8-K Current Report was filed by Mind Medicine (MindMed) Inc. on January 7, 2022, covering events occurring on January 5, 2022. The registrant is incorporated in British Columbia, Canada, and its Subordinate Voting Shares trade on The Nasdaq Stock Market LLC under the symbol MNMD. The company is classified as an emerging growth company.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes
- Board Resignation: On January 5, 2022, Mr. Stephen Hurst notified the Board of Directors of his decision to resign, effective immediately.
- Reason for Departure: The filing explicitly states that Mr. Hurst's resignation is not based on any disagreement with the Company or its management.
- Service History: Mr. Hurst had served on the Board of Directors since February 2020.
Guidance, Outlook, and Risks
The filing includes a Regulation FD Disclosure (Item 7.01) referencing a press release issued on January 7, 2022, regarding the director's departure. The document does not provide updated financial guidance, operational outlook, or specific risk factors beyond the standard disclosure that the press release is furnished but not "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the current composition of the Board of Directors following Mr. Hurst's immediate resignation.
- Review the press release (Exhibit 99.1) for any additional context regarding the resignation not included in the 8-K text.
- Confirm whether the company intends to appoint a replacement director to fill the vacancy.
- Note that this filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.